Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) shares surged 12.07 percent to close at $7.52 a share Thursday. The stock traded between $7.05 and $7.56 on volume of 57.25 million shares traded. The Daily Mail has reported that three major pharmaceutical groups (Eli Lilly, GlaxoSmithKline and Shire) have made “friendly approaches” to gain a major control in the company. Shares of Ariad Pharmaceuticals have fallen approximately 60.0 percent in the past year.
Get more information on Ariad Pharmaceuticals and free access to the in-depth equity report at:
www.FiveStarEquities.com/ARIA
CEL-SCI Corporation (NYSEMKT: CVM) shares jumped 12.62 percent to close at $1.16 a share Thursday. The stock traded between $1.06 and $1.17 on volume 11.62 million shares traded. The company announced that it has gained government approval in Sebia to begin a Phase II clinical trial of Multikine in head and neck cancer. Shares of CEL-SCI have fallen approximately 60.0 percent in the past year.
Get more information on CEL-SCI and free access to the in-depth equity report at:
www.FiveStarEquities.com/CVM
Nektar Therapeutics (NASDAQ: NKTR) shares gained 6.79 percent to close at $13.99 a share Thursday. The stock traded between $12.96 and $14.12 on volume 6.50 million shares traded. The company priced a public offering of 8.5 million shares of its common stock at a price of $12.75 a share. Shares of Nektar Therapeutics have are up approximately 55.0 percent in the past year.
Get more information on Nektar Therapeutics free access to the in-depth equity report at:
www.FiveStarEquities.com/NKTR
NetScout Systems, Inc. (NASDAQ: NTCT) shares spiked 14.36 percent to close at $36.48 a share Thursday. The stock traded between $33.57 and $36.70 on volume 1.54 million shares traded. The company reported GAAP revenues were $110.4 million for the third quarter of fiscal 2014, an increase of 21.0 percent when compared to a year ago. Shares of NetScout Systems have gained approximately 45.0 percent in the past year.
Get more information on NetScout Systems and free access to the in-depth equity report at:
www.FiveStarEquities.com/NTCT
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Five Star Equities
[email protected]